Tumor vascular architecture and function evaluated by non‐invasive susceptibility MRI methods and immunohistochemistry

To investigate the physiological origins responsible for the varying blood oxygenation level dependent (BOLD) magnetic resonance imaging (MRI) responses to carbogen (95% O2/5% CO2) breathing observed with different tumor types.

[1]  J R Griffiths,et al.  Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours , 2001, NMR in biomedicine.

[2]  J R Griffiths,et al.  BOLD MRI of human tumor oxygenation during carbogen breathing , 2001, Journal of magnetic resonance imaging : JMRI.

[3]  M. Dewhirst,et al.  In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: Validation by intravital microscopy , 2001, Magnetic resonance in medicine.

[4]  M. Décorps,et al.  Vessel size imaging , 2001, Magnetic resonance in medicine.

[5]  J R Griffiths,et al.  Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases. , 2001, Magnetic resonance imaging.

[6]  D M Shames,et al.  MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. , 2001, Radiology.

[7]  A R Padhani,et al.  In vivo monitoring of tumor angiogenesis with MR imaging. , 2000, Academic radiology.

[8]  R. Mason,et al.  Noninvasive investigation of blood oxygenation dynamics of tumors by near-infrared spectroscopy. , 2000, Applied optics.

[9]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[10]  R J Hodgkiss,et al.  Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. , 2000, International journal of radiation oncology, biology, physics.

[11]  J R Griffiths,et al.  Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. , 1999, Magnetic resonance imaging.

[12]  G Le Duc,et al.  Use of T2‐weighted susceptibility contrast MRI for mapping the blood volume in the glioma‐bearing rat brain , 1999, Magnetic resonance in medicine.

[13]  Michal Neeman,et al.  In Vivo Prediction of Vascular Susceptibility to Vascular Endothelial Growth Factor Withdrawal Magnetic Resonance Imaging of C6 Rat Glioma in Nude Mice , 1999 .

[14]  A. Heerschap,et al.  Global HDO uptake in human glioma xenografts is related to the perfused capillary distribution , 1999, Magnetic resonance in medicine.

[15]  J L Evelhoch,et al.  Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.

[16]  A. W. Simonetti,et al.  Effect of carbogen breathing on the physiological profile of human glioma xenografts , 1999, Magnetic resonance in medicine.

[17]  M. Neeman,et al.  Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. , 1999, Neoplasia.

[18]  D. Chaplin,et al.  Tumour vasculature as a target for cancer therapy. , 1999, British journal of cancer.

[19]  F. Howe,et al.  Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging , 1999, NMR in biomedicine.

[20]  D Artemov,et al.  Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. , 1999, Topics in magnetic resonance imaging : TMRI.

[21]  G. Rosner,et al.  The effects of hyperoxic and hypercarbic gases on tumour blood flow , 1999, British Journal of Cancer.

[22]  Franklyn A. Howe,et al.  Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo , 1999 .

[23]  B R Rosen,et al.  NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.

[24]  S. Roberts,et al.  High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  J R Griffiths,et al.  Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. , 1998, Seminars in radiation oncology.

[26]  M. Neeman,et al.  Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging , 1998, Magnetic resonance in medicine.

[27]  G S Karczmar,et al.  Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. , 1998, International journal of radiation oncology, biology, physics.

[28]  J R Griffiths,et al.  The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging. , 1997, International journal of radiation oncology, biology, physics.

[29]  F. Howe,et al.  The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. , 1997, British Journal of Cancer.

[30]  G L Rosner,et al.  Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. , 1996, The British journal of cancer. Supplement.

[31]  A. Harris,et al.  Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis , 1995, The Journal of pathology.

[32]  F. Howe,et al.  Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. , 1995, International journal of radiation oncology, biology, physics.

[33]  B R Rosen,et al.  Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.

[34]  A. J. van der Kogel,et al.  Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. , 1995, Microvascular research.

[35]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[36]  S. Ogawa,et al.  Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.

[37]  J. Griffiths,et al.  Potential artefacts from overlying tissues in 31p NMR spectra of subcutaneously implanted rat tumours , 1989, NMR in biomedicine.

[38]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[39]  P. Vaupel,et al.  Effect of injectable or inhalational anesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. , 1988, Radiation research.

[40]  J. Gray,et al.  A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.

[41]  R. Gillies,et al.  Applications of magnetic resonance in model systems: tumor biology and physiology. , 2000, Neoplasia.

[42]  Michael Molls,et al.  Blood perfusion and microenvironment of human tumors : implications for clinical radiooncology , 1998 .

[43]  Ravi S. Menon,et al.  On the characteristics of functional magnetic resonance imaging of the brain. , 1998, Annual review of biophysics and biomolecular structure.

[44]  R. Coombes,et al.  N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis. , 1981, Journal of the National Cancer Institute.